BIOMAT Database Logo BIOMAT Database Logo

Dose escalation study of carbon ion radiotherapy for locally advanced carcinoma of the uterine cervix. 2006

Shingo Kato, and Tatsuya Ohno, and Hirohiko Tsujii, and Takashi Nakano, and Jun-Etsu Mizoe, and Tadashi Kamada, and Tadaaki Miyamoto, and Hiroshi Tsuji, and Hirotoshi Kato, and Shigeru Yamada, and Susumu Kandatsu, and Kyosan Yoshikawa, and Hidefumi Ezawa, and Michiya Suzuki, and
Research Center Hospital for Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, Japan. s.kato@nirs.go.jp

OBJECTIVE To evaluate the toxicity and efficacy of carbon ion radiotherapy (CIRT) for locally advanced cervical cancer by two phase I/II clinical trials. METHODS Between June 1995 and January 2000, 44 patients were treated with CIRT. Thirty patients had Stage IIIB disease, and 14 patients had Stage IVA disease. Median tumor size was 6.5 cm (range, 4.2-11.0 cm). The treatment consisted of 16 fractions of whole pelvic irradiation and 8 fractions of local boost. In the first study, the total dose ranged from 52.8 to 72.0 gray equivalents (GyE) (2.2-3.0 GyE per fraction). In the second study, the whole pelvic dose was fixed at 44.8 GyE, and an additional 24.0 or 28.0 GyE was given to the cervical tumor (total dose, 68.8 or 72.8 GyE). RESULTS No patient developed severe acute toxicity. In contrast, 8 patients developed major late gastrointestinal complications. The doses resulting in major complications were > or =60 GyE. All patients with major complications were surgically salvaged. The 5-year local control rate for patients in the first and second studies was 45% and 79%, respectively. When treated with > or =62.4 GyE, the local control was favorable even for the patients with stage IVA disease (69%) or for those with tumors > or =6.0 cm (64%). CONCLUSIONS In CIRT for advanced cervical cancer, the dose to the intestines should be limited to <60 GyE to avoid major complications. Although the number of patients in this study was small, the results support continued investigation to confirm therapeutic efficacy.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011832 Radiation Injuries Harmful effects of non-experimental exposure to ionizing or non-ionizing radiation in VERTEBRATES. Radiation Sickness,Radiation Syndrome,Injuries, Radiation,Injury, Radiation,Radiation Injury,Radiation Sicknesses,Radiation Syndromes,Sickness, Radiation,Sicknesses, Radiation,Syndrome, Radiation,Syndromes, Radiation
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas

Related Publications

Shingo Kato, and Tatsuya Ohno, and Hirohiko Tsujii, and Takashi Nakano, and Jun-Etsu Mizoe, and Tadashi Kamada, and Tadaaki Miyamoto, and Hiroshi Tsuji, and Hirotoshi Kato, and Shigeru Yamada, and Susumu Kandatsu, and Kyosan Yoshikawa, and Hidefumi Ezawa, and Michiya Suzuki, and
Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer.
October 2004, International journal of radiation oncology, biology, physics,
Shingo Kato, and Tatsuya Ohno, and Hirohiko Tsujii, and Takashi Nakano, and Jun-Etsu Mizoe, and Tadashi Kamada, and Tadaaki Miyamoto, and Hiroshi Tsuji, and Hirotoshi Kato, and Shigeru Yamada, and Susumu Kandatsu, and Kyosan Yoshikawa, and Hidefumi Ezawa, and Michiya Suzuki, and
Carbon-ion radiotherapy for locally advanced or unfavorably located choroidal melanoma: a Phase I/II dose-escalation study.
March 2007, International journal of radiation oncology, biology, physics,
Shingo Kato, and Tatsuya Ohno, and Hirohiko Tsujii, and Takashi Nakano, and Jun-Etsu Mizoe, and Tadashi Kamada, and Tadaaki Miyamoto, and Hiroshi Tsuji, and Hirotoshi Kato, and Shigeru Yamada, and Susumu Kandatsu, and Kyosan Yoshikawa, and Hidefumi Ezawa, and Michiya Suzuki, and
Multi-Institutional Retrospective Analysis of Carbon-Ion Radiotherapy for Patients with Locally Advanced Adenocarcinoma of the Uterine Cervix.
May 2021, Cancers,
Shingo Kato, and Tatsuya Ohno, and Hirohiko Tsujii, and Takashi Nakano, and Jun-Etsu Mizoe, and Tadashi Kamada, and Tadaaki Miyamoto, and Hiroshi Tsuji, and Hirotoshi Kato, and Shigeru Yamada, and Susumu Kandatsu, and Kyosan Yoshikawa, and Hidefumi Ezawa, and Michiya Suzuki, and
Radiotherapy dose escalation with concurrent chemotherapy in locally advanced cervix cancer is feasible.
January 2016, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico,
Shingo Kato, and Tatsuya Ohno, and Hirohiko Tsujii, and Takashi Nakano, and Jun-Etsu Mizoe, and Tadashi Kamada, and Tadaaki Miyamoto, and Hiroshi Tsuji, and Hirotoshi Kato, and Shigeru Yamada, and Susumu Kandatsu, and Kyosan Yoshikawa, and Hidefumi Ezawa, and Michiya Suzuki, and
Radical radiotherapy for locally advanced cancer of uterine cervix.
August 2004, Cancer research and treatment,
Shingo Kato, and Tatsuya Ohno, and Hirohiko Tsujii, and Takashi Nakano, and Jun-Etsu Mizoe, and Tadashi Kamada, and Tadaaki Miyamoto, and Hiroshi Tsuji, and Hirotoshi Kato, and Shigeru Yamada, and Susumu Kandatsu, and Kyosan Yoshikawa, and Hidefumi Ezawa, and Michiya Suzuki, and
Dose escalation for patients with locally advanced nasopharyngeal carcinoma treated with radiotherapy alone.
August 2007, American journal of clinical oncology,
Shingo Kato, and Tatsuya Ohno, and Hirohiko Tsujii, and Takashi Nakano, and Jun-Etsu Mizoe, and Tadashi Kamada, and Tadaaki Miyamoto, and Hiroshi Tsuji, and Hirotoshi Kato, and Shigeru Yamada, and Susumu Kandatsu, and Kyosan Yoshikawa, and Hidefumi Ezawa, and Michiya Suzuki, and
Proton and carbon ion radiation therapy for locally advanced pancreatic cancer: A phase I dose escalation study.
April 2020, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.],
Shingo Kato, and Tatsuya Ohno, and Hirohiko Tsujii, and Takashi Nakano, and Jun-Etsu Mizoe, and Tadashi Kamada, and Tadaaki Miyamoto, and Hiroshi Tsuji, and Hirotoshi Kato, and Shigeru Yamada, and Susumu Kandatsu, and Kyosan Yoshikawa, and Hidefumi Ezawa, and Michiya Suzuki, and
[Combined treatment for locally advanced carcinoma of uterine cervix].
September 2002, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Shingo Kato, and Tatsuya Ohno, and Hirohiko Tsujii, and Takashi Nakano, and Jun-Etsu Mizoe, and Tadashi Kamada, and Tadaaki Miyamoto, and Hiroshi Tsuji, and Hirotoshi Kato, and Shigeru Yamada, and Susumu Kandatsu, and Kyosan Yoshikawa, and Hidefumi Ezawa, and Michiya Suzuki, and
Dose escalation in locally advanced carcinoma of the prostate.
April 2003, Seminars in radiation oncology,
Shingo Kato, and Tatsuya Ohno, and Hirohiko Tsujii, and Takashi Nakano, and Jun-Etsu Mizoe, and Tadashi Kamada, and Tadaaki Miyamoto, and Hiroshi Tsuji, and Hirotoshi Kato, and Shigeru Yamada, and Susumu Kandatsu, and Kyosan Yoshikawa, and Hidefumi Ezawa, and Michiya Suzuki, and
Chemoradiotherapy for locally advanced pancreatic cancer: a radiotherapy dose escalation and organ motion study.
September 2008, Clinical oncology (Royal College of Radiologists (Great Britain)),
Copied contents to your clipboard!